Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) EPS (Basic) (2016 - 2025)

DarioHealth filings provide 13 years of EPS (Basic) readings, the most recent being $1.07 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 43.39% to $1.07 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.35, a 38.56% decrease, with the full-year FY2025 number at $10.12, down 17.52% from a year prior.
  • EPS (Basic) hit $1.07 in Q4 2025 for DarioHealth, down from $2.96 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $4.91 in Q3 2024 to a low of $0.08 in Q2 2024.
  • Median EPS (Basic) over the past 5 years was $0.69 (2022), compared with a mean of $1.01.
  • The widest YoY moves for EPS (Basic): up 902.04% in 2024, down 86.21% in 2024.
  • DarioHealth's EPS (Basic) stood at $1.09 in 2021, then tumbled by 52.29% to $0.52 in 2022, then decreased by 21.15% to $0.41 in 2023, then surged by 360.98% to $1.89 in 2024, then tumbled by 43.39% to $1.07 in 2025.
  • The last three reported values for EPS (Basic) were $1.07 (Q4 2025), $2.96 (Q3 2025), and $0.18 (Q2 2025) per Business Quant data.